In recent years, ENO1 has been characterized by (1) cell surface localization; (2) high expression in cancer cells; and (3) its expression being positively associated with poor prognosis18,45, which has been considered a novel tumor marker and therapeutic target, consistent with our conclusion. This evidence concerns the gene ENO1 and cancer.